Sessioni Poster


DEMENTIA AND ALZHEIMER DISEASE

26/10/2017 / 19.00 - 21.00
103THE 6-(METHYLSULFINYL)HEXYL ISOTHIOCYANATE AS NEUROPROTECTIVE AGENT IN A MURINE MODEL OF ALZHEIMER'S DISEASE
1)Sita G. 2)Morroni F. 3)Graziosi A. 4)Tarozzi A. 5)Hrelia P.
127GEBR-32A, A NEW PROMISING PDE4D INHIBITOR FOR TREATMENT OF ALZHEIMER'S DISEASE
1)Balbi M.. 2)Rebosio C.. 3)Brullo C.. 4)Prickaerts J.. 5)Arancio O.. 6)Bruno O.. 7)Calcagno E.. 8)Ricciarelli R.. 9)Fedele E..
154EFFECT OF PALMYTOILETHANOLAMIDE IN 3XTG-AD ASTROCYTES AS AN IN VITRO MODEL OF ALZHEIMER'S DISEASE
1)Bronzuoli MR. 2)Facchinetti R. 3)Letizia A. 4)Cassano T. 5)Steardo L. 6)Scuderi C.
161BEHAVIOURAL AND NEUROPATHOLOGICAL EFFECTS OF INTRANASAL INSULIN TREATMENT IN A TRIPLE-TRANSGENIC MOUSE MODEL OF ALZHEIMER'S DISEASE (3×TG-AD)
1)Calcagnini S. 2)Barone E. 3)Lavecchia AM. 4)Lancioni M. 5)Meconi A. 6)Perluigi M. 7)Cassano T.
246EFFECT OF ULTRAMICRONIZED-PALMYTOILETHANOLAMIDE ON ASTROCYTE DYSFUNCTION IN A TRIPLE TRANSGENIC MODEL OF ALZHEIMER'S DISEASE
1)Facchinetti R.. 2)Bronzuoli MR. 3)Letizia A.. 4)Cassano T.. 5)Steardo L.. 6)Scuderi C..
250cGMP MODULATES LONG-TERM POTENTIATION AND MEMORY BY ENHANCING ABETA PRODUCTION
1)Fedele E. 2)Rebosio C. 3)Balbi M. 4)Calcagno E. 5)Gulisano W. 6)Arancio O. 7)Palmeri A. 8)Puzzo D. 9)Ricciarelli R.
392NEUROPROTECTIVE EFFECTS OF THE NOVEL MARINE CAROTENOID FUCOXANTHIN IN HUMAN NEURONAL SH-SY5Y CELLS
1)Pruccoli L. 2)Sita G. 3)Morroni F. 4)Hrelia P. 5)Tarozzi A.
422THE CONTRIBUTION OF MICROGLIA TO THE ENHANCED SYNAPTIC ACTIVITY THAT PRECEDES AB-INDUCED NEURONAL DEATH
1)Spampinato SF. 2)Merlo S. 3)Beneventano M. 4)Sortino MA.